Table 1.
Correlation of demographics and disease characteristics
| Parent/guardian and child demographics and disease characteristics | Total (N=136) | Not contemplating starting a CBD product for child (N=47) | Contemplating starting a CBD product for child (N=79) and using CBD product for child (N=10) | P-value |
|---|---|---|---|---|
| Respondent parent/guardian age in years (mean +/- SD) | 29.7 (8) | 26.5 (7) | ||
| Respondent Parent/guardian Gender- Female N (%) | 119 (87) | 42 (89) | 77 (86) | |
| Race/ethnicity- N (%) | ||||
| White/Caucasian | 132 (97) | 44 (94) | 88 (98.9) | |
| Black/African American | 2 (1) | 1 (2) | 1 (1.1) | |
| Asian American | 2 (1) | 2 (4) | 0 | |
| Parent/guardian education level | ||||
| High School or GED | 20 (16) | 2 (4) | 18 (21) |
χ2= 8.03 p=0.045* |
| Some college but no degree | 26 (19) | 7 (15) | 19 (22) | |
| Associate degree | 26 (19) | 12 (26) | 14 (16) | |
| Bachelor’s degree or higher | 62 (46) | 26 (55) | 36 (41) | |
| Income level- US dollars per year | ||||
| Less than 19,000 | 3 (2) | 1 (2) | 2 (2) |
χ2= 1.34 p= 0.72 |
| 20,000 to 49,000 | 27 (20) | 7 (15) | 20 (22) | |
| 50,000 to 99,000 | 41 (30) | 13 (28) | 28 (32) | |
| 100,000 or more | 65 (48) | 26 (55) | 39 (44) | |
| Child’s age in years- (mean +/- SD) | 11 (4) | 11.9 (4) | ||
| Child gender: Female- N (%) | 95 (70) | 31 (66) | 64 (72) | |
| JIA duration N (%) | ||||
| < 6 months | 2 (1) | 2 (4) | 0 |
χ2= 1.45 p= 0.69 |
| 6-12 months | 9 (7) | 3 (6) | 6 (6) | |
| > 12- 24 months | 20 (15) | 7 (15) | 13 (15) | |
| > 24 months | 105 (77) | 35 (75) | 70 (79) | |
| JIA Subtype N (%) | ||||
| Oligoarticular | 47 (35) | 19 (47) | 28 (32) |
χ2= 7.93 p= 0.13 |
| Polyarticular | 53 (39) | 12 (26) | 41 (46) | |
| Psoriatic arthritis | 6 (4) | 3 (2) | 3 (3) | |
| Systemic | 14 (10) | 8 (17) | 6 (7) | |
| Ankylosing spondylitis | 2 (1) | 0 | 2 (2) | |
| Enthesitis related arthritis | 1 (0.7) | 1 (2) | 0 | |
| Unsure | 12 (9) | 3 (6) | 9 (10) | |
| Current disease activity N (%) | ||||
| Active | 59 (44) | 15 (29) | 44 (49) |
χ2= 9.56 p= 0.022* |
| Inactive on medication | 49 (36) | 16 (34) | 33 (37) | |
| Inactive off medication for < 1 year | 18 (13) | 11 (23) | 7 (7.8) | |
| Clinical remission | 10 (7) | 5 (10) | 5 (5.6) | |
| Current medications reported using N (%) | ||||
| None | 22 (16) | 10 (21) | 12 (13) |
χ2= 2.47 p= 0.48 |
| NSAID | 69 (51) | 23 (49) | 46 (51) | |
| Non-biologic DMARD | 51 (38) | 18 (38) | 33 (37) | |
| Biologic DMARD | 65 (48) | 18 (38) | 47 (52) | |
aColumn percentages are displayed
bP-values derived from the chi-squared (χ 2 ) or Wilcoxon tests
cDMARDs disease-modifying antirheumatic drugs, NSAIDs nonsteroidal anti-inflammatory drugs
dMedication categories are not mutually exclusive, therefore, medications do not sum to 100%